Related Experiment Video
Updated: Mar 7, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
Therapeutic Application of Adult Stem Cells in the Heart
Taylor A Johnson1, Dinender K Singla2
1Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, University of Central Florida, 4110 Libra Dr., Orlando, FL, USA.
Insights
Adult stem cells (ASCs) show promise for treating heart diseases like myocardial infarction and heart failure. Unlike other stem cells, ASCs avoid teratoma formation and immune concerns, making them safer for human therapeutic applications.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Cell therapies are investigated for treating heart conditions such as myocardial infarction, doxorubicin-induced cardiomyopathy, and heart failure.
- Embryonic stem cells (ESCs) and adult stem cells (ASCs) have been studied in preclinical and clinical research.
- ASCs offer advantages over ESCs and induced pluripotent stem cells (iPSCs) by not posing a teratoma risk and avoiding immune system concerns, positioning them as suitable for human therapeutic use.
Purpose of the Study:
- To review the characteristics and sources of adult stem cells and progenitor cells.
- To evaluate the efficacy of ASC transplantation in experimental and clinical trials for cardiovascular diseases.
- To suggest future research directions for advancing the therapeutic applications of ASCs.
Main Methods:
- Comprehensive literature review of studies on adult stem cells and progenitor cells.
- Analysis of preclinical animal models and clinical trial data for cell transplantation efficacy.
- Synthesis of information on stem cell sources, characteristics, and therapeutic outcomes.
Main Results:
- ASCs possess distinct characteristics and diverse sources suitable for regenerative medicine.
- Transplantation of ASCs has demonstrated efficacy in preclinical and clinical settings for various heart conditions.
- ASCs present a favorable safety profile compared to other pluripotent stem cells, reducing risks of teratoma formation and immune rejection.
Conclusions:
- Adult stem cells represent a viable and safe cell-based therapeutic strategy for cardiovascular diseases.
- Further research into ASCs' mechanisms and optimization of delivery methods can enhance their clinical translation.
- ASCs hold significant potential for developing novel treatments for heart failure and other cardiac pathologies.
Abstract:
Cell therapies have been explored as a potential treatment avenue to treat heart diseases, such as myocardial infarction, doxorubicin-induced cardiomyopathy, and heart failure. Embryonic and adult stem cells (ASCs) have been examined in animal and clinical settings. Unlike embryonic and induced pluripotent stem cells, ASCs do not pose a threat to form teratomas, nor do they have immune system concerns, making them ideal for therapeutic use in humans. In this review, we will investigate different characteristics and sources of adult stem cells and progenitor cells, as well as determine their efficacy in cell transplantation in experimental and clinical trials. In addition, we will propose other research avenues that may promote further understanding and use of ASCs in therapeutic designs.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Adult Stem Cells
Mesenchymal Stem Cells
iPS Cell Differentiation

